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ABSTRACT
Transgender individuals show brain structural alterations that differ from their biological sex as
well as their perceived gender. To substantiate evidence that the brain structure of transgender
individuals differs from male and female, we use a combined multivariate and univariate approach.
Gray matter segments resulting from voxel-based morphometry preprocessing of N = 1753 cisgender
(CG) healthy participants were used to train (N = 1402) and validate (20% hold-out N = 351) a
support vector machine classifying the biological sex. As a second validation, we classified N =
1104 patients with depression. A third validation was performed using the matched CG sample of
the transgender women (TW) application sample. Subsequently, the classifier was applied to N = 25
TW. Finally, we compared brain volumes of CG-men, women and TW pre/post treatment (CHT) in a
univariate analysis controlling for sexual orientation, age and total brain volume. The application of
our biological sex classifier to the transgender sample resulted in a significantly lower true positive
rate (TPR-male = 56.0%). The TPR did not differ between CG-individuals with (TPR-male = 86.9%)
and without depression (TPR-male = 88.5%). The univariate analysis of the transgender application
sample revealed that TW pre/post treatment show brain structural differences from CG-women and
CG-men in the putamen and insula, as well as the whole-brain analysis. Our results support the
hypothesis that brain structure in TW differs from brain structure of their biological sex (male) as well
as their perceived gender (female). This finding substantiates evidence that transgender individuals
show specific brain structural alterations leading to a different pattern of brain structure than CG
individuals.
Keywords Neuroimaging · Machine Learning · Gender Dysphoria · Depression · Structural MRI · Brain Development
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1 Introduction
Being transgender describes the stable feeling to belong to the opposite rather than the biological sex assigned at birth,
while the term cisgender (CG) describes the feeling of coherence between biological sex and perceived gender. If a
transgender individual suffers from distress due to incoherence between perceived gender and biological sex, the DSM
5 allows the diagnosis of gender dysphoria [1]. Distinguishing between being a transgender individual, and suffering
from gender dysphoria, is important to destigmatize transgender individuals. A diagnosis of gender dysphoria allows
transgender individuals access to psychiatric treatment if distress is experienced.
Although there is an ongoing social and political debate regarding the terms and phrases used to describe gender, little
is known about how a divergence between biological sex and perceived gender emerges. A popular view is that sexual
brain differentiation and body development are incoherent in transgender individuals [2]. Evidence for this comes
from studies in female infants with congenital adrenal hyperplasia, who develop male playing behavior [3, 4]. Due
to prenatally circulating testosterone, the brain of such female infants is structurally organized as a male brain, while
their body development is female [3, 4]. Female infants with this condition often identify themselves as a member
of the male gender, even if congenital adrenal hyperplasia is treated after birth. According to this view, the brain of
transgender individuals would be organized incoherently to their body already at birth [5, 6, 2].
Previous research provides extensive information on how brain structure differs as a function of biological sex. Briefly,
sex differences in CG-individuals are most notable in areas concerning emotion perception/regulation, reward, and
motor control [7]. While CG-men show higher gray matter volume in general, CG-women show larger volume of
limbic structures. However, sexual differentiation seems less prominent in the brain compared to physical appearance
[8, 9]. While sexual development appears to be dimorphic, the brain is responsible for many functions that are shared by
males and females [10]. Hence, brains cannot easily be classified into dimorphic categories, as is the case for physical
appearance [11].
Multivariate and univariate analysis of brain structure in transgender individuals have been used to substantiate evidence
towards gender- and sex-specific brain structural alterations. However, the investigation of structural brain alterations
in transgender individuals is challenging, since it is difficult to control for important confounders, such as hormonal
treatment (CHT), sexual orientation or comorbid psychiatric disorders (e.g. Major Depressive Disorder (MDD)). Low
sample sizes minimize statistical power to detect structural brain changes.
Few ROI-based approaches have studied how brain structure of transgender individuals differs from CG. Compared
to CG-men, transgender women (biological sex male, perceived gender female, TW) show structural alterations of
the putamen [12], the temporo-parietal junction, the inferior frontal cortex and the insulae [13], as well as the angular
gyrus and the inferior parietal lobulus [14]. Elevated cortical thickness in transgender individuals compared to CG is
the only result replicated in three studies [15, 16]. However, all previous results fit with the idea that structural brain
changes in areas involved in body perception (e.g. insula, putamen) are associated with the feeling of incoherence
between biological sex and perceived gender. The reported studies only investigated individuals before cross-sex
hormone treatment (CHT). Comparisons between TW pre/post CHT with CG individuals exhibited heterogeneous
results [17, 18, 19, 20, 21, 22, 10]. CHT in TW combines treatment with anti-androgens and estradiol that are associated
with region-specific structural alterations of the brain [23]. CHT has been associated with volume and cortical thickness
decreases e.g. in regions associated with emotional learning [24, 19]. However, longitudinal studies are scarce and a
recent large study did not find any differences between TW pre and post CHT [20, 10]. Next to univariate analyses,
multivariate approaches offer new insights into the similarities and differences between cisgender and transgender
individuals [25, 26]. In two studies, pattern classification was used to investigate whether transgender adolescents could
be separated from CG-adolescents by their patterns of volumetric differences. Both cases show decreased accuracy in
biological sex classification in transgender individuals compared to CG individuals. Specifically, in one study, a trained
biological sex classifier reached 88% accuracy in the CG-sample, but the accuracy for transgender adolescents was
considerably lower (below 60%), whether treated or not. However, it has been recently criticized that classifiers trained
with small sample sizes lead to high accuracies, but low external validity, especially when applied to small samples [27].
Hence, in the present study, we trained and validated a biological sex classifier with large samples of cisgender controls
without any psychiatric comorbidities. We then applied the classifier to a smaller sample of TW and CG-men and
-women, whose data were recorded at the same time and in the same scanner. To ensure that observed misclassification
is not caused or biased by psychiatric comorbidity, we performed a second validation of the classifier in an additional
large validation sample with MDD patients. A third validation was performed in a matched CG sample of the TW
application sample. Our hypotheses for the multivariate analysis are:
(1) The classifier trained on healthy CG-participants shows significantly worse performance when applied to a
sample of TW
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(2) The classifier trained on healthy CG-participants performs equally well in a validation sample of CG-patients
suffering from major
Following our multivariate approach, we used a univariate analysis in two regions of interest that have been associated
with brain structural alterations in TW. We investigated local structural brain alterations in the putamen and the insula
[28, 29, 10, 13, 12, 16] corrected for total intracranial volume, age and sexual orientation. Previous results regarding
brain structural alterations of TW in the respective regions have been heterogeneous. Since TW differ in brain structure
from CG-men and –women, we hypothesize that
(3) CG-women show lower volume in comparison to CG-men in both regions of interest [7].
(4) TW pre and post CHT show increased volume in comparison to CG-women (perceived gender of TW)
(5) TW pre and post CHT show lower volume in comparison to CG-men (biological sex of TW)
(6) Since we expect CHT to lead to a further feminization of brain structure and hence reduced volume, we
hypothesize that TW pre CHT show higher volume in comparison to TW post CHT.
2 Materials and Method
2.1 Procedure
To obtain a predictor for biological sex based on structural MRI brain scans, a pipeline was created that optimizes a
support vector machine (SVM). This classifier was trained on a large sample of CG-individuals without any psychiatric
disorder. To achieve an optimal training result, the parameters of the SVM (hyperparameters) were refined using
a Bayesian method with nested 10-fold cross-validation. An independent random sample of 20%, drawn from
the population in advance, served as the first validation set, to avoid the risk of overfitting during hyperparameter
optimization (supplementary Figure 4). To rule out that depressive symptoms influence the performance of the predictor
in our TW group, we used a second validation sample with MDD patients. Next, the classifier was applied to data from
TW individuals, and to a third validation group whose data were acquired at the same time and with the same scanner
as the TW sample. This control group was also included in the univariate region-of-interest analysis that followed the
multivariate analyses. Two regions previously associated with changes in TW relative to CG individuals were examined:
the putamen and the insula.
2.2 Data
2.2.1 Cisgender training sample and first validation set
The data from a sample of N = 1753 CG participants without any evidence of previous psychiatric disorders served as
the basis for the training. History of psychiatric disorders was ruled out using the Structured clinical interview following
DSM-IV criteria [30]. The participants were taken from three different cohorts: the Muenster Neuroimaging Cohort
(MNC, N = 666 [31]), the BiDirect (BD, N = 434 [32]) study and the FOR2107 study (N = 653 [33]). Exclusion criteria
for the MNC were presence or history of major internal or neurological disorder, dependence on or recent abuse of
alcohol or drugs, hypertension, and general MRI contraindications. BD and FOR2107 have similar exclusion criteria;
details are described in supplementary table 3 and elsewhere [34, 33].
2.2.2 Second, clinical validation sample – patients suffering from major depressive disorder (MDD)
To exclude that potential differences in classification true-positive rate are due to comorbid depressive symptoms in TW,
data from a clinical sample (N = 1404) of patients diagnosed with MDD were used as second validation-test sample.
Diagnoses were again verified with the structural clinical interview according to DSM-IV criteria [30]. The MDD
sample consisted of N = 285 participants from the MNC, N = 591 from the BD study and N = 528 from the FOR2107
study (supplementary table 3). Additional exclusion criteria were presence of bipolar disorder, schizoaffective disorders
and schizophrenia, substance-related disorders, current benzodiazepine treatment (wash out of at least three half-lives
before study participation), and recent electroconvulsive therapy. Nearly all patients were under psychopharmacological
antidepressant treatment and/or received psychotherapy.
2.2.3 Application: transgender application sample including third validation sample
To test for a different classification of CG and TW individuals, we used an independent sample of N = 26 TW. Data for
this transgender sample were collected in conjunction with a set of cisgender controls that serve as the third validation
sample of N = 19 CG-women and N = 15 CG-men (Transgender study (TSS)). Data of TW and CG were recorded
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under equal conditions (e.g. scanner, timeframe, study protocol, investigator), ruling out possible confounding of the
SVM due to scanner variability. The TW were in different treatment states, with 18 already treated with hormones
(supplementary table 4). Further details can be found in the original study [35].
2.3 Image acquisition and structural preprocessing
T1-weighted high-resolution anatomical images of the MNC and TSS were acquired at a 3T MRI (Gyroscan Intera
3T, Philips Medical Systems, the Netherlands) using a three-dimensional fast gradient echo sequence (turbo field
echo), repetition time = 7.4ms, echo time = 3.4ms, flip angle = 9◦, two signal averages, inversion pre-pulse every
814.5ms, acquired over a field of view of 256 (feet-head) × 204 (anterior-posterior) × 160mm3 (right-left), frequency
encoding in feet to head direction, phase encoding in anterior-posterior and right-left direction, reconstructed to voxels
of 0.5× 0.5× 0.5mm3 [36, 37].
The 3D T1-weighted turbo field echo images of the BD study were collected in the same scanner with repetition time =
7.26ms, echo time = 3.56ms, 9◦ flip angle, 160 sagittal slices, matrix dimension 256× 256, FOV = 256× 256mm,
2mm slice thickness (reconstructed to 1mm) resulting in a voxel size of 1 × 1 × 1mm3. The FOR2107 study
was conducted at two different sites [38]. In Münster, data were collected with a 3T Siemens PRISMA using 3D
T1-weighted magnetization prepared rapid acquisition gradient echo (MPRAGE) with repetition time = 1900ms, echo
time = 2.28ms, inversion time = 900ms, 8◦ flip angle, 192 sagittal slices, 0mm slice gap, resulting in a voxel size
of 1× 1× 1mm3. In Marburg, data were collected in a 3T Siemens Magnetom Trio Tim syngo MR B17 using a 3D
T1-weighted magnetization prepared rapid acquisition gradient echo (MPRAGE) with repetition time = 1900ms, echo
time = 2.26ms, inversion time = 900ms, 9◦ flip angle, 176 sagittal slices, 0.5mm slice lap, resulting in a voxel size of
1× 1× 1mm3. The structural images were preprocessed using the CAT12-toolbox [39] (version r1184) in all four
cohorts (MNC, FOR2107, BiDirect, TSS) following published protocols. Briefly, images were bias-corrected, tissue
classified and normalized to MNI-space [40]. For the univariate analysis, images were additionally smoothed with a
Gaussian kernel of 8mm full width half maximum (FWHM). Absolute threshold masking with a threshold value of 0.1
was used for all univariate second-level analyses (http://www.neuro.uni-jena.de/cat12/CAT12-Manual.pdf).
We carefully checked the sample for poor image quality detected by visual inspection and with the check homogeneity
using covariance function implemented in CAT12.
2.4 Analyses
2.4.1 Multivariate analysis
Individualized prediction of the biological sex was assessed with a support vector classifier, implemented in the Scikit-
learn toolbox [41]. CAT12 whole-brain gray matter images were used as a classifier input. Gray matter images were
resliced to a voxel size of 3× 3× 3mm3, to reduce dimensionality while preserving maximal localized morphometric
differences. The training process was strictly separated from the evaluation, by selecting a random validation set of
20% (N = 351, female = 219, male = 132), which was not used during classifier training and testing. The remaining
data set of N = 1402 subjects was balanced for sex with a random undersampling procedure (N = 1218, female = 609,
male = 609), and used in a 10-fold split procedure resulting in balanced training sets of 1096 subjects in each fold. A
principal-component analysis was performed next, to further reduce the dimensionality of the data. The maximum
number of principal components is limited to 1096, the number of subjects resulting from the 10-fold split. We carried
out a Bayes-statistic-based hyperparameter optimization for the SVC (Scikit-Optimize [42]), nested in the 10-fold
cross-validation. The parameter search included choice of the kernel (radial basis function (rbf) or linear), the C
parameter (10−2 to 102, non-discrete log-scale), which influences penalties for misclassification, and the γ parameter
(10−6 to 10, non-discrete log-sale), influencing the curvature of the decision boundary. In this iterative Bayes approach,
a total of 100 parameter combinations were evaluated. Quality and classifier performance are reported by area under the
ROC curve (AUC). The classifier resulting from the best combination of hyperparameters was finally determined using
our first validation set, the 20% drawn in advance from the original sample. To exclude potential effects of comorbid
depression, this step was repeated with the sample of MDD subjects, as a second validation sample (Figure 1).
The final trained and validated classifier was then applied to the application sample with transgender individuals. To
test if classification results differ between CG-men and TW (same biological sex), we applied the true positive rate
(TPR). Since balanced accuracy is a measure not applicable to one-group-only scenarios. Fisher’s exact test was used to
clarify whether TPR differs statistically between samples. Interpretation of TPR is based on the hypothesis that TW
belong to the category of male biological sex.
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Figure 1: Application of the trained classifier for biological sex prediction.
Abbreviations: CG - cisgender
TW - transgender women
MDD - major depression disorder
2.4.2 Univariate analysis
The TSS sample (TW group and matched CG controls, supplementary table 4) were used in the univariate analysis.
Statistical parametric mapping (SPM12, Wellcome Trust Centre for Neuroimaging, London, http://www.fil.ion.
ucl.ac.uk/spm/) was used for univariate gray matter analysis. The putamen and insula were defined as a priori
regions of interest (ROIs) using the aal-atlas [40] implemented in the Wake Forest University Pickatlas (http:
//fmri.wfubmc.edu/software/PickAtlas). We investigated the relationship between groups (CG-men, -women,
TW-pre and -post CHT) and gray-matter volume with an ANCOVA, with age, total intracranial volume and sexual
orientation as nuisance regressors in all analyses. Sexual orientation was indicated by the participants as a continuous
variable (0 indicating homosexuality, 50 indicating bisexuality and 100 indicating heterosexuality). The terminology
was chosen according to the natal biological sex of TW, i.e. homosexuality indicated sexual interest in men. We
calculated a priori defined t-contrasts according to our hypothesis: CG-men > women, CG-men > TW-pre, TW-pre
> CG-women, CG-men > TW-post, TW-post > CG-women and TW pre > TW post. An additional whole brain
analysis further explored possible regions with volume differences between the groups. To determine statistical
significance of putative clusters in each of the two bilateral ROIs (insula, putamen) and the whole brain analysis, the
non-parametric approach of Threshold-Free Cluster Enhancement was used, as implemented in the TFCE toolbox
(http://dbm.neuro.uni-jena.de/tfce, version 167). Rigorous alpha correction was applied at a threshold of
family-wise-error-corrected p < .05 obtained by 5000 permutations per test.
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3 Results
3.1 Multivariate analysis
3.1.1 Cisgender training and first validation sample
The training of the classifier led to two results. The first result was the estimation of a hyperparameter set, determined
with the Bayes optimization method. The hyperparameter optimization estimated a rbf kernel, C = 27.3 and
γ = 2.4×10−5 for the SVM as optimal approximation for the present problem. Based on the estimated hyperparameters,
the second result was the classification outcome of the 20% validation set, which provided a performance indication for
the trained classifier. The balanced accuracy for the validation set classification was 94.01%. The confusion matrix
(supplementary table 6) revealed that our classifier assigns the female biological sex (TPR = 99.9%) more accurately
than the male biological sex (TPR = 88.5%). These results are visualized by a ROC curve, based on the probabilities
for a classification as male (supplements figure 2a), with a calculated area under the curve (AUC) of 0.99.
3.1.2 MDD second validation sample
To rule out that MDD comorbidity had any influence on the classifier, we used a second validation set consisting of
1404 MDD subjects (853 CG-women, 551 CG-men). Our classifier reached a balanced accuracy of 92.06%, and a
TPR of 86.93% for CG-men in this sample (supplementary table 7). The results of the classifier, the corresponding
ROC curve (supplementary figure 2d), and the AUC of 0.99 are similar to the results of the first validation set. Fisher’s
exact test revealed no significant differences between the distribution of results of the first and second validation sample
(supplementary table 8).
3.1.3 Transgender application sample and cisgender third validation sample
The balanced accuracy for the third validation sample was 94.03% (CG part of the transgender sample). The TPR
for CG-men was 93.3% and for CG-women 94.7%. However, the TPR for the TW was remarkably low at 56%
(supplementary table 6); see visualization by ROC curves (supplementary figure 2b, c). The corresponding AUC differed
as a function of group between 0.99 (CG-men) and 0.95 (TW). This difference in TPR was significant, as Fisher’s exact
test showed a statistically significant difference between TPR of CG-men and TW with hormone treatment (Table 1).
The output probabilities of the classifier are represented descriptively in figure 2, as a box plot.
TPR in % Fisher’s Exact Test
Group N (N correct/total) against CG men
CG-women 19 94.74 (18/19) p = .813
CG-men 15 93.33 (14/15) -
TW 25 56.00 (14/25) p = .013 ***
TW (treatment naive) 9 77.77 (7/9) p = .308
TW (post CHT) 18 50.00 (9/18) p = .008 ***
Table 1: Classification results in the application sample. Classification results in percentage of true positive rate
identified biological sex.
Abbreviations: TPR - true positive rate (sensitivity)
CG - cisgender
TW - transgender women
CHT - cross-sex-hormone treatment
3.2 Univariate analysis
The region of interest analysis is summarized in table 2 and figure 3 (see coordinates and detailed statistics there).
Briefly, using rigorous alpha correction, our analysis revealed no differences between TW-post CHT and CG-women
in the bilateral putamen. In the insula, TW-post CHT showed higher volume than CG-women. TW-post CHT and
CG-women both showed lower volume of the insula and putamen compared to CG-men. In contrast, TW-pre CHT
showed larger volume in both ROI analyses compared to CG-women. Interestingly, TW pre CHT also showed higher
volume in the putamen compared to CG-men. TW post-CHT showed lower volume of both regions of interest compared
to TW pre-CHT in both regions of interest. CG-men showed larger volume in both regions of interest compared to
CG-women. Detailed results of our exploratory whole-brain analysis can be found in the supplementary table 9. The
analysis revealed higher volumes in TW-pre compared to CG-women and TW post treatment in areas such as the
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Figure 2: Boxplot for the predicted probabilities of male sex based on the application sample and the third validation
sample, including transgender and cisgender individuals.
Abbreviations: CG - cisgender
TW - transgender women
precuneus, and medial cingulate cortex while TW-post treatment showed higher volumes compared to CG-women in
the precuneus and lingual gyrus, but also lower volume compared to CG-women in the postcentral gyrus as well as
lower volumes compared to CG-men in the precentral and frontal inferior gyrus.
4 Discussion
In the present study, we developed an SVM using hyperparameter optimization resulting in an accurate classification of
biological sex based on structural MRI images. The classifier, trained on a large training set of healthy CG individuals,
performed equally well in three independent validation samples of healthy CG individuals, and CG participants suffering
from MDD. When applying the same classifier to structural MRI data of TW, the SVM shows a much lower TPR,
resulting in significantly more misclassifications of the biological sex of TW (male) in favor of their perceived gender
(female). Moreover, the descriptive statistics of classification probabilities regarding TW (Figure 2) indicate a pattern
of prediction uncertainty that is not seen in CG. Hence, our results shed light on two important aspects in biological
psychiatry of transgender individuals: 1) The impact of hormonal treatment on brain structure, 2) the separation of
psychological distress (i.e. depression), hormonal treatment and trait characteristics of being a transgender individual.
Our results replicate the finding that biological sex is increasingly misclassified in transgender individuals, previously
described by Hoekzema and colleagues (2015) [25]. This might encourage further investigations into the cause for
increased misclassifications in TW. Most notably and in contrast to previous studies, we could rule out that our findings
are biased by comorbid depression. Given that the results of the first validation sample of healthy CG participants were
replicated in a large clinical sample of CG psychiatric patients suffering from major depression, the classifier appears to
be reliable and robust to noise even from psychiatric disorders such as MDD, which have been associated with structural
brain changes [43, 44]. Our biological sex classifier shows a higher external validity than other biological sex classifiers.
First, it has been tested on controls and patients with MDD, with high and very similar accuracy. Second, the SVM has
been trained on large samples that have been collected at different sites. Hence, our SVM can be regarded as more
generalizable while preserving performance and accuracy, indicating its robustness to noise. In the present work, we
focused on the first application of this SVM on TW. We observed that our SVM was increasingly inaccurate in TW,
compared to healthy CG controls. The explorative analysis revealed that this inaccuracy was particularly increased in
TW who had hormonal treatment. Although our TW pre CHT sample size was low, we aimed to differentiate structural
brain alterations between TW pre and TW post CHT as well as in comparison to CG-women and -men. TW showed
brain structural alterations dependent on their treatment state. Volumes of the insula and putamen were larger in TW pre
CHT than in CG-women, while TW post CHT showed lower volumes of the right insula compared to CG-women. Our
7
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region MNI-space
compared groups of interest side TFCE p-FWE k x y z
TW-pre > TW-post
insula
L 91.50 .012 76 -38 -3 -12
R 54.96 .033 23 32 10 -16
putamen
L 466.55 <.001 2005 -21 16 8
R 395.31 <.001 1409 27 -8 15
TW-pre > CG-women
insula
L 63.21 <.001 1926 -39 -3 -12
R 52.58 <.001 2299 34 15 -10
putamen
L 274.31 <.001 2381 -21 10 23
R 257.58 <.001 2316 26 -4 14
TW-pre > CG-men putamen
L 203.55 <.001 892 -21 15 9
R 183.13 <.001 576 28 -3 15
TW-post < CG-men
insula
L 38.96 .005 303 -42 14 -6
L 30.99 .010 124 -42 -8 4
R 21.37 .001 131 30 -18 20
putamen
L 100.64 .001 1050 -14 9 -2
R 70.60 .001 1429 26 4 -8
TW-post < CG-women insula R 114.58 .021 99 34 -15 9
CG-men > CG-women
insula
L 49.7 <.001 1199 -44 14 -8
L 13.07 .004 48 -44 -14 8
R 109.23 <.001 1789 39 16 3
putamen
L 81.13 <.001 1972 26 6 -4
R 100.11 <.001 1429 26 4 -8
Table 2: Results of the univariate gray matter region of interest analysis of the insula and putamen.
Note. Table reports respective statistics of significant clusters of the group comparisons between transgender
and cisgender individuals. Clusters resulted from group comparisons corrected for total intracranial volume,
age and sexual orientation. For reasons of brevity no results below a threshold of k = 22 voxel have been
reported.
Abbreviations:
TW - Transgender Women
CG - cisgender
pre/post - before/after hormone treatment
L/R - left/right
k - cluster size
TFCE - Threshold-Free-Cluster-Enhancement with subsequent Family-Wise-Error-Correction.
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Figure 3: Significant results of the univariate gray matter analysis. Color-bar represents t-values of the extracted
clusters. Image shows the cluster at the respective peak voxel as reported in table 2. A. Alterations of the
insula between groups (cisgender men, cisgender women and transgender women before vs. after hormone
treatment) B. Alterations of the putamen between groups (cisgender men, cisgender women transgender
women before vs. after hormone treatment)
whole-brain analysis also revealed that TW pre resemble large clusters with higher gray matter volume than CG-women,
while TW post CHT showed more pronounced brain structural alterations compared to CG-women. While TW post
CHT showed higher volume in a few brain areas compared to CG-women, they showed lower volume in the postcentral
gyrus. In comparison to CG-men, TW-pre CHT showed larger volumes of the putamen, while TW-post CHT showed
lower volumes of both insula and putamen. Accordingly, the whole-brain analysis revealed that TW-pre CHT showed
higher volumes in comparison to CG-men in several large clusters, while TW-post CHT showed lower volumes in
comparison to CG-men. Thus, TW independent of treatment state show brain structural alterations in our regions of
interest and across the brain in comparison to both, CG-men and –women. Detailed analysis of TW-pre compared to
-post CHT revealed a less pronounced pattern of structural brain alterations in TW-post CHT compared to CG-women.
Comparing TW-pre with TW-post CHT revealed lower volume of TW post CHT in both regions of interest, as well as
the whole-brain analysis. This implies that CHT induces a further feminization of brain structure in TW. This result
fits with previous longitudinal studies that have shown reductions of cortical thickness in TW pre to post CHT [16].
Structural and functional alterations of the insula have consistently been associated with transgender compared to CG
individuals [45, 28, 29, 10, 13]. The insula is associated with body and self-perception. Behaviorally, TW perceive
an incoherence between their biological sex and perceived gender that is accompanied by altered insula activity in
response to bodily sensations [46].
Brain structural alterations of the putamen have been associated with TW across multiple studies and independent of
treatment state (pre, post CHT) [13, 12, 17]. We examined the putamen volume across different treatment states. Our
study reveals that TW-pre show a higher volume of the putamen compared to CG-men and CG-women, while TW-post
show lower volume of the putamen compared to CG-men, but not to CG-women. However, it remains unknown how
CHT influences these structural and functional brain alterations of TW. Longitudinal examinations are required to
reveal region specific structural alterations especially in the insula and putamen to estimate the impact of CHT of brain
structure.
Our combined univariate and multivariate approach revealed associations of CHT with lower accuracy in detecting
the biological sex (male) in TW. Our results imply that brain structure of TW (especially post CHT) does neither
resemble a feminine nor masculine brain. In line with this idea, hormonal processes, brain-structural development and
9
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the development of gender identity are intertwined [21]. Intrauterine hormones (e.g. testosterone) drive the development
of gender identity, rather than social learning processes [47, 48]. The male physical appearance is formed in the first
trimester, due to effects of testosterone, and the female body develops due to the lack of androgens in this period [49].
While the maturation of reproductive organs is more or less limited to the first trimester, brain development is continuing
throughout pregnancy [50, 5]. Hormonal influences after the first trimester do not change the biological sex, but the
experience of gender. Thus, hormonal influences after the first trimester might be responsible for the incoherence
between biological and experienced sex. Since hormonal influences change gender perception as well as brain structure,
CHT may lead to misclassifications in the TW group after treatment. Our univariate data indeed show that CHT is
associated with structural brain alterations comparing TW pre and post CHT to CG individuals. A previous study
showed increased misclassification of biological sex even in untreated TW, which we could not statistically support
due to the small sample size of our untreated group (N = 8). Therefore, further studies should follow up on this effect,
with higher sample sizes of untreated TW to increase power. An extension of the design with a second control group
(women with hormonal treatment) should be used to clarify whether misclassification is an effect of treatment only, due
to the combination of being transgender and CHT.
Structural brain alterations in TW compared to CG individuals are also discussed in the context of psychiatric
comorbidity and distress. In the present study, we addressed this by testing our SVM on CG-patients with MDD and
obtained the same accuracy as for CG-individuals without MDD. Presumed that distress experienced by MDD patients
is comparable to distress in TW, we found no evidence that structural alterations from distress are responsible for the
decreased accuracy of our classifier in TW. The present SVM approach provides a new tool for research in biological
psychiatry. Prevalence of many psychiatric disorders is often higher for one biological sex than for the other. For
example, prevalence in autism is higher for biological men than for biological women. Hence, it was hypothesized
that female patients with autism might be similar in their brain structure to men. A previous study that developed a
biological sex classifier using structural MRI scans and applied it to patients with autism [51] indeed showed increased
misclassifications of biological sex in female patients with autism. Therefore, biological sex misclassifications (as
found in autism, but not in our depressed validation sample reported here) might point to involvement of aberrant
biological sex development in the onset of such neurodevelopmental disorders. Future studies could use our trained
classifier (https://photon-ai.com/model_repo/bsc_mri) to test for misclassifications in other clinical diagnoses
with high gender imbalance in prevalence rates, such as eating disorders, substance use disorders, or anxiety disorders.
4.1 Limitations
Due to our small sample size of transgender individuals, replication of the prediction failure of our SVM in transgender
individuals pre and post CHT is needed. To verify that our effect is due to hormonal treatment, larger samples and
studies in transgender men (biological sex female) are needed. Future studies should further dissect effects of gender
dysphoria from depression, and effects of hormonal treatment from the state of being a transgender individual. Finally,
a sample of transgender men would have been desirable to investigate whether the current finding generalizes to
transsexual individuals with female biological sex.
5 Conclusion
In this study, we present a highly accurate biological sex classifier in CG individuals that shows a significantly decreased
accuracy in transgender individuals after CHT. Our results underline that the brain structure of transgender individuals
is similar to both, the brain structure of their perceived gender and biological sex. This implies that brain structure of
TW differs from both cg men and women. Based on our brain structural data, we suggest a dimensional rather than
binary gender construct which will contribute to the destigmatization of transgender individuals.
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A Supplements
Male Female Significance test
Muenster Neuroimaging Cohort
Healthy Controls (Nmale = 278; Nfemale = 388)
Age 36.4 (11.7) 35.8 (12.6) F (1, 665) = 0.4917, p = .480
Major Depressive Disorder (Nmale = 121; Nfemale = 164)
Age 37.4 (11.3) 38.1 (12.4) F (1, 284) = 0.253, p = .615
BDI 23.4 (9.5) 26.5 (10.9) F (1, 274) = 6.212, p = .013
HDRS-17 18.5 (3.8) 19.5 (4.5) F (1, 187) = 2.739, p = .100
IQ (MWBT) 111.5 (13.3) 110.9 (14.1) F (1, 267) = 2.739, p = .765
BiDirect
Healthy Control Group (Nmale = 217; Nfemale = 217)
Age 51.3 (8.1) 53.0 (8.0) F (1, 433) = 4.481, p = .035
Major Depressive Disorder (Nmale = 235; Nfemale = 356)
Age 48.1 (7.4) 49.6 (7.3) F (1, 590) = 5.612, p = .019
HDRS-17 12.6 (6.8) 14.3 (6.5) F (1, 587) = 10.160, p = .002
FOR2107
Healthy Control Group (Nmale = 246; Nfemale = 407)
Age 32.6 (11.4) 32.6 (13.0) F (1, 652) = 0.001, p = .976
Major Depressive Disorder (Nmale = 195; Nfemale = 333)
Age 36.6 (13.8) 37.8 (13.4) F (1, 527) = 0.719, p = .397
HDRS-17 8.9 (6.7) 8.5 (6.8) F (1, 525) = 0.414, p = .520
Table 3: Descriptive statistics of the trainings and validation samples. Table reports means and standard deviations of
the individual cohorts used for the training of the support vector machine. Significance test was univariate
ANOVA without covariates.
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CG men CG women TW pre TW post
(N = 15) (N = 19) (N = 8) (N = 18) significance test
Age 34 32 33.9 33.1
F (3, 56) = 0.190, p = .991
in yeares (8.6) (6.3) (14.1) (31.3)
Highest 4.9 4.8 5.0 5.1
F (3, 56) = 0.802, p = .498
Education (0.9) (0.8) (0.0) (0.5)
Table 4: Descriptive statistics of the application sample (transgender and cisgender individuals). Table reports means
and standard deviations of the transgender individuals and controls from a similar measurement period used
for the test of the support vector machine in TW. Significance test was univariate ANOVA without covariates.
From 15 out of 29 TW were requested whether they had a depressive episode and 8 from the 15 TW indicated
that they had a depressive episode. TW = transgender women (biological sex male, perceived sex female),
Highest Education = Education was measured according to educational attainment in numbers from 1 = special
school to 6 = universal degree.
actual
group female male
pr
ed
ic
te
d female
202 17
(TPR = 99.9%) (TNR = 11.5%)
male
1 131
(TNR = 0.1%) (TPR = 88.5%)
Accuracy 94.87%
Balanced Accuracy 94.01%
Precision 99.24%
Recall 88.51%
F1-Score 0.9357
Table 5: Results of the validation set (N = 351; Nmale = 148; Nfemale = 203). Classification results in absolute
numbers and percentage of accurately identified biological sex.
Abbreviations: TPR - true positive rate (sensitivity)
TNR - true negative rate (specificity)
actual
group CG women CG men TW
pr
ed
ic
te
d female
18 1 11
(TPR = 94.7%) (TNR = 6.7%) (TNR = 44.0%)
male
1 14 14
(TNR = 5.3%) (TPR = 93.3%) (TPR = 56.0%)
The following metrics are
related to the CG groups only:
Accuracy 94.12%
Balanced Accuracy 94.03%
Precision 93.33%
Recall 93.33%
F1-Score 0.9333
Table 6: Results of the application set (N = 59; NCG men = 148; NCG women = 203; NTW = 25). Classification results
in absolute numbers and percentage of accurately identified biological sex.
Abbreviations: TPR - true positive rate (sensitivity)
TNR - true negative rate (specificity)
CG - cisgender
TW - transgender women
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Figure 4: Overview of training, validation and application procedure of the biological sex classifier.
Abbreviations: SVM - support vector machine
PCA - principal component analysis
actual
group female male
pr
ed
ic
te
d female
829 72
(TPR = 97.2%) (TNR = 13.1%)
male
24 479
(TNR = 2.8%) (TPR = 86.9%)
Accuracy 93.16%
Balanced Accuracy 92.06%
Precision 95.23%
Recall 86.93%
F1-Score 0.9206
Table 7: Results of the second validation set (N = 1404; Nmale = 551; Nfemale = 853). Classification results in
absolute numbers and percentage of accurately identified biological sex.
Abbreviations: TPR - true positive rate (sensitivity)
TNR - true negative rate (specificity)
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validation set 1 validation set 2 Fisher’s Exact Test
N correct/incorrect N correct/incorrect p-value
CG women 131/17 479/72 .7386
CG men 202/1 829/24 .9955
Table 8: Comparison of the distribution of classification results between the first and second validation sets, using
Fisher’s exact test. (CG - cisgender)
0.0 0.2 0.4 0.6 0.8 1.0
False Positive Rate
0.0
0.2
0.4
0.6
0.8
1.0
Tr
ue
Po
si
tiv
e
R
at
e
Baseline
AUC = 0.99
(a) First validation sample: CG men
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(b) Third validation sample: CG men
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(c) Application sample: TW (biological sex male)
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(d) Second Validation sample: MDD CG men
Figure 5: Receiver Operation Characteristics for the classification as biological sex male for cisgender men in first,
second and third validation sample as well transgender women of our application sample.
CG = cisgender
MDD = Major Depressive Disorder
TW = transgender women
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MNI-Space
compared groups region of interest TFCE p-FWE k x y z
TW-pre > TW-post
R medial cingulate cortex 1643.35 .005 15117 27 -9 16and caudate nucleus
L caudate nucleus 1514.98 .005 13228 -22 18 12
L precentral and middle frontal gyrus 766.08 .029 470 -36 4 54
L precuneus 743.23 .029 651 -14 -56 52
L postcentral gyrus 668.59 .040 410 -63 -14 39
R cerebellum 632.84 .045 505 48 -54 -27
R cerebellum 611.18 .047 258 40 -38 -46
TW-pre > CG-women
L precuneus, R medial cingulate Cortex, 982.71 <.001 108742 22 -3 15L + R lingual gyrus
L cerebellum 328.77 .003 4657 -30 -33 -50
R precentral, frontal inferior gyrus 127.46 .041 360 62 16 27
TW-post > CG-women R calcarine/lingual gyrus, precuneus 1312.08 <.001 3875 4 -50 3L cuneus, superior occipital gyrus 605.11 .023 498 -10 -96 36
TW-post < CG-women R postcentral gyrus 1057.71 .026 562 45 -21 32
TW-pre > CG-men
L caudate nucleus, putamen, hippocampus 745.18 .009 3018 -21 18 9
R caudate nucleus, putamen 713.97 .010 2336 28 -4 16
R Precuneus, Mid Cingulum 673.63 .013 3185 8 -28 39
L Pre-, Postcentral 654.18 .015 822 -69 -15 -32
R Hippocampus, Parahippocampus 567.93 .028 713 20 -8 -30
R Calcarine, Lingual gyrus 528.98 .002 416 26 -75 3
TW-post < CG-men
L middle temporal lobe, cerebellum 939.61 <.001 111736 32 -56 -38R middle temporal lobe, cerebellum
R precentral and frontal inferior gyrus 260.12 .016 628 57 6 12
Table 9: Results of the whole-brain analysis. For reasons of brevity only significant clusters > k = 300 voxels are
reported, we did not calculate a contrast comparing cisgender men and women. The reported significant
clusters resulted from group comparisons within a full factorial model corrected for total intracranial volume,
age and sexual orientation.
Abbreviations: TW - Transgender Women
CG - cisgender
pre/post - before/after hormone treatment
L/R - left/right
k - cluster size
TFCE - Threshold-Free-Cluster-Enhancement with subsequent Family-Wise-Error-Correction.
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